Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A hospital discharge opioid taper support intervention to improve post-operative opioid prescribing

Award Number: K23DA055752
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 05/01/2023
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

A hospital discharge opioid taper support intervention to improve post-operative opioid prescribing - ABSTRACT This K23 application from Dr. Justina Groeger proposes a mentored research and career development plan that will advance her goal of becoming a leading physician-investigator who tests health systems strategies to minimize opioid-related harms, particularly among older adults (age ≥65). Post-operative care is a time when excessive opioid prescribing occurs which can result in unnecessary harms, particularly to older and frail adults. An EHR-embedded, provider-facing, patient-specific, discharge opioid taper support (DOTS) intervention may reduce excessive post-operative opioid prescribing, but has not been rigorously tested, and even if made available in the EHR, provider- and patient- factors are likely to influence whether providers use the intervention for patients. The overarching goal of the proposed research is to rigorously test DOTS, an intervention with three components: 1) a recommendation for a patient-specific opioid taper schedule based on patient opioid use prior to discharge, 2) an automated default discharge opioid prescription based on the recommended taper schedule, and 3) post-discharge enhanced telephonic support for patients. We will randomize 42 providers to DOTS or telephonic support alone (TS) for 15-months, collect electronic health record data for their 1890 patients having orthopedic surgery, collect patient-reported outcomes from a subset of 100 (50 from providers in each group), and conduct a qualitative study of 21 DOTS providers. The specific aims are to: 1) determine the effectiveness of DOTS for reducing excessive opioid prescribing after orthopedic surgery, 2) test the impact of DOTS on patient-reported post-operative outcomes including pain intensity, physical function, and emergency post-operative care; and 3) identify determinants of provider use of DOTS. We hypothesize that compared to patients of TS providers, patients of DOTS providers will have favorable outcomes including reduction in excessive opioid prescribing and improved pain and function after surgery. By completing the proposed research and career development plan, Dr. Groeger will gain skills in 1) design and conduct of randomized controlled trials, 2) development and implementation of EHR-embedded interventions, 3) qualitative research methods, and 4) advanced longitudinal data analysis. The proposed research will lead to an R01 application to rigorously test DOTS at other hospitals and future trials testing DOTS at hospital discharge for other (non-orthopedic) causes of acute pain. With the completion of these activities and with the guidance of a team of multi-disciplinary mentors, Dr. Groeger will obtain the skills necessary to achieve her career goal of become a leading physician-investigator who tests health systems strategies to minimize opioid- related harms, particularly among older adults.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $195,696 )
2026	2026	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Drug Use and Addiction Research Programs	000	4	4/29/2026	NON-COMPETING CONTINUATION	$195,696
														Subtotal = $195,696

Issue Date FY: 2025 ( Subtotal = $195,696 )
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Drug Use and Addiction Research Programs	000	3	4/18/2025	NON-COMPETING CONTINUATION	$195,696
														Subtotal = $195,696

Issue Date FY: 2024 ( Subtotal = $195,696 )
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Drug Use and Addiction Research Programs	000	2	4/22/2024	NON-COMPETING CONTINUATION	$195,696
														Subtotal = $195,696

Issue Date FY: 2023 ( Subtotal = $195,696 )
2023	2023	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Drug Use and Addiction Research Programs	000	1	4/14/2023	NEW	$195,696
														Subtotal = $195,696

Grand Total All Awards = $782,784

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A hospital discharge opioid taper support intervention to improve post-operative opioid prescribing

Award Number: K23DA055752

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 05/01/2023

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer